In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).
October 6, 2023
September 27, 2023
Philips Respironics completed the analyses for System One and DreamStation Go sleep therapy devices indicating that the volatile organic compounds (VOCs) and the particulate matter (PM) emissions related to foam degradation are within the appliable safety limits. Additional visual assessments have been performed and confirm the low prevalence of significant foam degradation.
August 8, 2024
Click here to learn moreJune 13, 2023
Click here to learn moreJune 28, 2022
Click here to learn moreSeptember 3, 2021
Click here to learn moreYou are about to visit a Philips global content page
Continue